SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Moonwalk Biosciences, a pioneering epigenetic engineering and medicine company, announced it will present data highlighting its EpiRead and ...

Novel platform technology provides a complete view of the epigenome in health and disease, with the most advanced AI prediction of epigenetic targets, and the broadest set of epigenetic engineering ...

The MarketWatch News Department was not involved in the creation of this content. -- The EpiRead and EpiWrite platform will be presented for the first time highlighting high-resolution single-cell ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary ...

Scribe expects to initiate a first-in-human hypercholesterolemia study in mid-2026 with STX-1150, its lead cardiometabolic assetSTX-1150 is designed to deliver durable therapeutic LDL-C lowering with ...

Salk Institute researchers find new mode of epigenetic targeting, showing for the first time that genetic sequences can direct new DNA methylation patterns in plants LA JOLLA (November 21, 2025)—All ...

Episode 3 (January 5, 2024): Interview with co-founder and CEO of Moonwalk Biosciences and former CTO of Illumina, Alex Aravanis; Neuro gene therapy with Novartis and Voyager; GEN reporters look ...